PrimeRFP SCOUT · Federal Contract Recompete Brief

W81K0222F0037Fentanyl norfentanly reagent KITS for tripler — Alere San Diego, Inc

Alere San Diego, Inc holds $42.8M across 9,132 federal awards, concentrated at Department of Defense (DOD). PoP ended Mar 22, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Rhco Pacific
Awarding office
Alere San Diego, Inc
Recipient
Mar 22, 2022
PoP end
$187K
Obligated
$187K
Potential
325413
NAICS
6550
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Alere San Diego, Inc — $90

Contract facts

Federal
Contract numberW81K0222F0037
Also listed asW81K02-22-F-0037
Also listed asN6264520D5004-W81K0222F0037
AgencyW40m Rhco Pacific
Awarding officeW40m Rhco Pacific
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentAlere San Diego, Inc
CAGE6W6P3
UEITWMQTHHN6HM5
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDVN6264520D5004
Place of performanceSAN DIEGO CA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMar 1, 2022
PoP end (current)Mar 22, 2022
Obligated$187K
Current value$187K
Potential value$187K

FENTANYL/NORFENTANLY REAGENT KITS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII is a federal award for W40m Rhco Pacific held by Alere San Diego, Inc. Estimated value $187K ($187K obligated). Current period of performance ends Mar 22, 2022. Place of performance: SAN DIEGO CA.

FENTANYL/NORFENTANLY REAGENT KITS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII

Recompete timing

Public
Past PoP end (1613 days ago)

Current PoP ended Mar 22, 2022 (1613 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Alere San Diego, Inc$42.8M obligated across 9,132 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($42.8M) · all agencies · Top 3 shown (3%); remaining ~97% is other agencies.
Department of Defense (DOD)$770K · 2%
Court Services and Offender Supervision Agency (CSOSA)$625K · 1%
Department of Transportation (DOT)$51K · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81K0222F0037?

W81K0222F0037 (Fentanyl norfentanly reagent KITS for tripler) is a W40m Rhco Pacific award with a potential value of $187K, currently held by Alere San Diego, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81K02-22-F-0037?

W81K02-22-F-0037 is the dashed form of PIID W81K0222F0037 (Fentanyl norfentanly reagent KITS for tripler), held by Alere San Diego, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81K0222F0037?

W40m Rhco Pacific awarded W81K0222F0037 to Alere San Diego, Inc (potential $187K).

Who is the incumbent on W81K0222F0037?

Alere San Diego, Inc is the incumbent with $42.8M across 9132 related awards in SCOUT’s public footprint. The current period of performance ends Mar 22, 2022.

When does Alere San Diego, Inc’s W81K0222F0037 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 22, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81K0222F0037